BNP Paribas Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.5M Buy
467,753
+139,425
+42% +$21.4M 0.09% 232
2025
Q4
$57.2M Buy
328,328
+129,626
+65% +$23.7M 0.07% 268
2025
Q3
$28.6M Sell
198,702
-103,363
-34% -$12.7M 0.07% 266
2025
Q2
$30.4M Sell
302,065
-311,204
-51% -$23.8M 0.07% 259
2025
Q1
$46.8M Sell
613,269
-41,632
-6% -$3.18M 0.13% 169
2024
Q4
$45.2M Buy
654,901
+145,462
+29% +$10.5M 0.11% 192
2024
Q3
$37.2M Sell
509,439
-144,909
-22% -$10.7M 0.09% 219
2024
Q2
$43.8M Sell
654,348
-317,965
-33% -$12.3M 0.11% 193
2024
Q1
$26.4M Buy
972,313
+76,367
+9% +$2.14M 0.07% 265
2023
Q4
$27.8M Buy
895,946
+39,748
+5% +$1.03M 0.08% 257
2023
Q3
$21.6M Sell
856,198
-8,437
-1% -$193K 0.07% 279
2023
Q2
$18.2M Sell
864,635
-148,911
-15% -$2.83M 0.06% 302
2023
Q1
$17.3M Buy
1,013,546
+107,372
+12% +$2.09M 0.06% 319
2022
Q4
$18.1M Buy
906,174
+140,273
+18% +$2.71M 0.06% 318
2022
Q3
$16.5M Buy
765,901
+90,905
+13% +$2.18M 0.07% 318
2022
Q2
$13.3M Buy
674,996
+141,005
+26% +$2.95M 0.05% 355
2022
Q1
$12.5M Buy
+533,991
New +$12.4M 0.04% 376

Other funds holding INSM

BNP Paribas Asset Management's INSM Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Insmed (INSM) stake by 42% in Q1 2026, buying an estimated $21.4M and bringing the position to 467,753 shares worth $76.5M. The position accounts for 0.09% of the portfolio, ranked #232.

BNP Paribas Asset Management first reported a position in INSM in Q1 2022 and has held it in 17 quarters since. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • BNP Paribas Asset Management held 467,753 shares of Insmed worth $76.5M as of Q1 2026.
  • BNP Paribas Asset Management bought 139,425 Insmed shares in Q1 2026, an estimated $21.4M.
  • Insmed made up 0.09% of BNP Paribas Asset Management's portfolio in Q1 2026, its #232 holding.
  • BNP Paribas Asset Management first reported a position in Insmed in Q1 2022 and has held it in 17 quarters since.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.